|
1
|
Cieza A, Causey K, Kamenov K, Hanson SW,
Chatterji S and Vos T: Global estimates of the need for
rehabilitation based on the global burden of disease study 2019: A
systematic analysis for the global burden of disease study 2019.
Lancet. 396:2006–2017. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
GBD 2019 Diseases and Injuries
Collaborators. Global burden of 369 diseases and injuries in 204
countries and territories, 1990-2019: A systematic analysis for the
global burden of disease study 2019. Lancet. 396:1204–1222.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Assad M and Jackson N: Biocompatibility
evaluation of orthopedic biomaterials and medical devices: A review
of safety and efficacy models. In: Encyclopedia of Biomedical
Engineering. Vol 2. 1st edition. Narayan RJ (ed). Elsevier,
Amsterdam, pp281-309, 2019.
|
|
4
|
Bruinink A and Luginbuehl R: Evaluation of
biocompatibility using in vitro methods: Interpretation and
limitations. Adv Biochem Eng Biotechnol. 126:117–152.
2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Helmus MN, Gibbons DF and Cebon D:
Biocompatibility: Meeting a key functional requirement of
next-generation medical devices. Toxicol Pathol. 36:70–80.
2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bergmann CP and Stumpf A: Biomaterials.
In: Dental ceramics. Topics in mining, metallurgy and materials
engineering. Bergmann CP (ed) Springer, Heidelberg, pp9-15,
2013.
|
|
7
|
Rodríguez-González ÁF: Biomaterials in
Orthopaedic Surgery. ASM International, pp1-10, 2009.
|
|
8
|
Shekhwat D, Singh A, Banerjee MK, Singh T
and Patnaik A: Bioceramics composites for orthopaedic applications:
A comprehensive review of mechanical, biological, and
microstructural properties. Ceram Int. 47:3013–3030. 2021.
|
|
9
|
Kiradzhiyaska DD and Mantcheva RD:
Overview of biocompatible materials and their use in medicine.
Folia Med (Plovdiv). 61:34–40. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gobbi SJ, Gobbi JV and Rocha Y:
Requirements for selection/development of a biomaterial. Biomed J
Sci Tech Res. 14:10674–10679. 2019.
|
|
11
|
Navarro M, Michiardi A, Castaño O and
Planell JA: Biomaterials in orthopaedics. J R Soc Interface.
5:1137–1158. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Vandana U, Nancy D, Sabareeswaran A, Remya
NS, Rajendran N and Mohanan PV: Biocompatibility of strontium
incorporated ceramic coated titanium oxide implant indented for
orthopaedic applications. Mater Sci Eng B. 264(114954)2021.
|
|
13
|
Bommala VK, Krishna MG and Rao CT:
Magnesium matrix composites for biomedical applications: A review.
J Magnes Alloy. 7:72–79. 2019.
|
|
14
|
Kumar K, Das A and Prasad SB: Recent
developments in biodegradable magnesium matrix composites for
orthopaedic applications: A review based on biodegradability,
mechanical and biocompatibility perspective. Mater Today Proc.
44:2038–2042. 2021.
|
|
15
|
Nuss KMR and von Rechenberg B:
Biocompatibility issues with modern implants in bone-a review for
clinical orthopedics. Open Orthop J. 2:66–78. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Victor SP and Muthu J: Polymer ceramic
composite materials for orthopedic applications-relevance and need
for mechanical match and bone regeneration. J Mechatron. 2:1–10.
2014.
|
|
17
|
Aherwar A, Singh AK and Patnaik A: Current
and future biocompatibility aspects of biomaterials for hip
prosthesis. AIMS Bioeng. 3:23–43. 2016.
|
|
18
|
Kattimani VS, Kondaka S and Lingameneni
KP: Hydroxyapatite-past, present, and future in bone regeration.
Bone Tissue Regen Insights: Sep 11, 2016 (Epub ahead of print).
|
|
19
|
Rufino Senra M and Marques FV: Synthetic
polymeric materials for bone replacement. J Compos Sci.
4(191)2020.
|
|
20
|
Liu B and Lun DX: Current application of
β-tricalcium phosphate composites in orthopaedics. Orthop Surg.
4:139–144. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Samavedi S, Poindexter LK, Van Dyke M and
Goldstein AS: Synthetic biomaterials for regenerative medicine
applications. In: Regenerative Medicine Applications in Organ
Transplantation. Orlando G, Lerut J, Soker S and Stratta RJ (eds).
Academic Press, Boston, pp81-99, 2014.
|
|
22
|
Webb JC and Spencer RF: The role of
polymethylmethacrylate bone cement in modern orthopaedic surgery. J
Bone Joint Surg Br. 89:851–857. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cipurković A, Horozić E, Đonlagić N, Marić
S, Saletović M and Ademović Z: Biodegradable polymers: Production,
properties and application in medicine scientific review paper.
Technol Acta. 11:25–35. 2018.
|
|
24
|
Quinn J, McFadden R, Chan CW and Carson L:
Titanium for orthopedic applications: An overview of surface
modification to improve biocompatibility and prevent bacterial
biofilm formation. iScience. 28(10174)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Rahmati M, Silva EA, Reseland JE, Heyward
CA and Haugen HJ: Biological responses to physicochemical
properties of biomaterial surface. Chem Soc Rev. 49:5178–5224.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Cvrček L and Horáková M: Plasma modified
polymeric materials for implant applications. In: Non-Thermal
Plasma Technology for Polymeric Materials. Applications in
Composites, Nanostructured Materials and Biomedical Fields. Thomas
S, Mozetič M, Cvelbar U, Špatenka P and Praveen KM (eds). Elsevier,
Amsterdam, pp376-407, 2019.
|
|
27
|
Groth T, Falck P and Miethke RR:
Cytotoxicity of biomaterials-basic mechanisms and in vitro test
methods: A review. ATLA. 23:790–799. 1995.
|
|
28
|
Iqbal HMN and Keshavarz T: The challenge
of biocompatibility evaluation of biocomposites. In: Woodhead
Publishing Series in Biomaterials, Biomedical composites (second
edition). Ambrosio L (ed). Woodhead Publishing, Cambridge,
pp303-334, 2017.
|
|
29
|
Li W, Zhou J and Xu Y: Study of the in
vitro cytotoxicity testing of medical devices. Biomed Rep.
3:617–620. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kohl Y, Rundén-Pran E, Mariussen E, Hesler
M, El Yamani N, Longhin EM and Dusinska M: Genotoxicity of
nanomaterials: Advances in vitro models and high throughput methods
for human hazard assessment-a review. Nanomaterials (Basel).
10(1911)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Raghavendra GM, Varaprasad K and
Jayaramudu T: Biomaterials: Design, development and biomedical
applications. In: Nanotechnology Applications for Tissue
Engineering. Thomas S, Grohens Y and Ninan N (eds). Elsevier,
Amsterdam, pp21-44, 2015.
|
|
32
|
Moore MM, Honma M, Clements J, Bolcsfoldi
G, Burlinson B, Cifone M, Clarke J, Delongchamp R, Durward R,
Fellows M, et al: Mouse lymphoma thymidine kinase gene mutation
assay: Follow-up meeting of the international workshop on
genotoxicity testing-aberdeen, scotland, 2003-assay acceptance
criteria, positive controls, and data evaluation. Environ Mol
Mutagen. 47:1–5. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
OECD Guideline for the Testing of
Chemicals. In vitro mammalian cell gene mutation assays using the
thymidine kinase gene, 2014. Available from: https://www.oecd.org/env/ehs/testing/In%20Vitro%20Mammalian%20Cell%20Gene%20Mutation%20Thymidine%20Kinase%20.pdf.
|
|
34
|
OECD/OCED Guideline for the Testing of
Chemicals. In vitro mammalian chromosomal aberration test, 2016.
Available from: https://www.oecd-ilibrary.org/docserver/9789264264649-en.pdf?expires=1615635244&id=id&accname=guest&checksum=AD494BA2A538E6C1302075C64D4C7BA5.
|
|
35
|
Registre M and Proudlock R: The in vitro
aberration test. In: Genetic toxicology testing. Proudlock R (ed).
Academic Press, Amsterdam, pp207-267, 2016.
|
|
36
|
Jain AK, Singh D, Dubey K, Maurya R,
Mittal S and Pandey AK: Models and methods for in vitro toxicity.
In: In vitro Toxicology. Dhawan A and Kwon S (eds). Academic Press,
Amsterdam, pp45-65, 2018.
|
|
37
|
Guy RC: Ames test. In: Encyclopedia of
Toxicology. 2nd edition. Wexler P (ed). Elsevier, Amsterdam,
pp88-91, 2005.
|
|
38
|
De Jong WH, Caraway JW and Geertsma RE: In
vivo and in vitro testing for the biological evaluation of
biomaterials and medical devices. In: Woodhead Publishing Series in
Biomaterials, Biocompatibility and Performance of Medical Devices.
Boutrand JP (ed). Woodhead Publishing, Cambridge, pp120-158,
2012.
|
|
39
|
Kimber I, Basketter DA, Berthold K, Butler
M, Garrigue JL, Lea L, Newsome C, Roggeband R, Steiling W, Stropp
G, et al: Skin sensitization testing in potency and risk
assessment. Toxicol Sci. 59:198–208. 2001.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Nalezinková M: In vitro hemocompatibility
testing of medical devices. Thromb Res. 195:145–190.
2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Brănișteanu DE, Nichifor M, Dorobăț CM,
Brănișteanu DC, Petrariu FD, Molodoi AD, Radu DC and Boda D: Use of
textile biomaterials for the topic treatment of chronic venous
disease. Rom Biotechnol Lett. 20:10618–10625. 2015.
|
|
42
|
Weber M, Steinle H, Golombek S, Hann L,
Schlensak C, Wendel HP and Avci-Adali M: Blood-contacting
biomaterials: In vitro evaluation of the hemocompatibility. Front
Bioeng Biotechnol. 6(99)2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Anderson JM and Schoen FJ: In vivo
assessment of tissue compatibility. In Biomaterials Science. 3rd
edition. Ratner BD, Hoffman AS, Schien FJ and Lemons JE (eds).
Academic Press, Amsterdam, pp609-617, 2013.
|
|
44
|
Anderson JM and Jiang S: Animal models in
biomaterial development. In: Encyclopedia of biomedical
engineering. Narayan R (ed). Elsevier, Amsterdam, pp237-241,
2019.
|
|
45
|
Hakimi O, Vollrath F and Carr AJ:
Evaluation of silk as a scaffold for musculoskeletal
regeneration-the path from the laboratory to clinical trials. In:
Comprehensive biotechnology. 2nd edition. Moo-Young M (ed).
Academic Press, Amsterdam, pp341-351, 2011.
|
